Table of contents

Volume 93, Issue 8
Published online 11 October 2005 (849-961)

Top

Minireviews

Proton beam therapy FREE

W P Levin, H Kooy, J S Loeffler and T F DeLaney

Br J Cancer 93: 849-854; advance online publication, September 27, 2005; doi:10.1038/sj.bjc.6602754

Circulating endothelial progenitor cells FREE

B Garmy-Susini and J A Varner

Br J Cancer 93: 855-858; advance online publication, September 27, 2005; doi:10.1038/sj.bjc.6602808

Top

Clinical Studies

Sex hormones and oesophageal adenocarcinoma: influence of childbearing? FREE

J Lagergren and C Jansson

Br J Cancer 93: 859-861; advance online publication, September 27, 2005; doi:10.1038/sj.bjc.6602810

Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting FREE

L Kotaniemi-Talonen, P Nieminen, A Anttila and M Hakama

Br J Cancer 93: 862-867; advance online publication, September 27, 2005; doi:10.1038/sj.bjc.6602799

A phase I pharmacokinetic and pharmacodynamic study of BGC9331 and carboplatin in relapsed gynaecological malignancies FREE

T Benepal, A Jackman, L Pyle, S Bate, A Hardcastle, W Aherne, F Mitchell, L Simmons, R Ruddle, F Raynaud and M Gore

Br J Cancer 93: 868-875; doi:10.1038/sj.bjc.6602811

A Phase I study of the angiogenesis inhibitor SU5416 (semaxanib) in solid tumours, incorporating dynamic contrast MR pharmacodynamic end points FREE

A O'Donnell, A Padhani, C Hayes, A J Kakkar, M Leach, J M Trigo, M Scurr, F Raynaud, S Phillips, W Aherne, A Hardcastle, P Workman, A Hannah and I Judson

Br J Cancer 93: 876-883; doi:10.1038/sj.bjc.6602797

Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in advanced head and neck cancer FREE

M Tsukuda, A Kida, M Fujii, N Kono, T Yoshihara, Y Hasegawa, M Sugita and Chemotherapy Study Group of Head and Neck Cancer

Br J Cancer 93: 884-889; advance online publication, September 27, 2005; doi:10.1038/sj.bjc.6602804

The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population FREE

R O Illing, J E Kennedy, F Wu, G R ter Haar, A S Protheroe, P J Friend, F V Gleeson, D W Cranston, R R Phillips and M R Middleton

Br J Cancer 93: 890-895; advance online publication, September 27, 2005; doi:10.1038/sj.bjc.6602803

Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III study FREE

S De Placido, M Lopez, C Carlomagno, G Paoletti, S Palazzo, L Manzione, C Iannace, G P Ianniello, F De Vita, C Ficorella, A Farris, G Pistillucci, M Gemini, E Cortesi, V Adamo, N Gebbia, S Palmeri, C Gallo, F Perrone, G Persico and A R Bianco

Br J Cancer 93: 896-904; doi:10.1038/sj.bjc.6602800

Under utilisation of the 2-week wait initiative for lung cancer by primary care and its effect on the urgent referral pathway FREE

N R Lewis, I Le Jeune and D R Baldwin

Br J Cancer 93: 905-908; advance online publication, September 27, 2005; doi:10.1038/sj.bjc.6602798

The risk of thrombo-embolic events is increased in patients with germ-cell tumours and can be predicted by serum lactate dehydrogenase and body surface area FREE

A-C Piketty, A Fléchon, A Laplanche, E Nouyrigat, J-P Droz, C Théodore and K Fizazi

Br J Cancer 93: 909-914; advance online publication, October 4, 2005; doi:10.1038/sj.bjc.6602791

Top

Molecular Diagnostics

Differential response to gefitinib of cells expressing normal EGFR and the mutant EGFRvIII FREE

M W Pedersen, N Pedersen, L H Ottesen and H S Poulsen

Br J Cancer 93: 915-923; advance online publication, September 27, 2005; doi:10.1038/sj.bjc.6602793

No common denominator for breast cancer lymph node metastasis FREE

B Weigelt, L F A Wessels, A J Bosma, A M Glas, D S A Nuyten, Y D He, H Dai, J L Peterse and L J van't Veer

Br J Cancer 93: 924-932; advance online publication, September 27, 2005; doi:10.1038/sj.bjc.6602794

Strong expression of ID1 protein is associated with decreased survival, increased expression of ephrin-A1/EPHA2, and reduced thrombospondin-1 in malignant melanoma FREE

O Straume and L A Akslen

Br J Cancer 93: 933-938; advance online publication, September 27, 2005; doi:10.1038/sj.bjc.6602792

Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphoma FREE

C Schrader, D Janssen, W Klapper, J-U Siebmann, P Meusers, G Brittinger, M Kneba, M Tiemann and R Parwaresch

Br J Cancer 93: 939-945; advance online publication, September 27, 2005; doi:10.1038/sj.bjc.6602795

Top

Genetics and Genomics

Identification of human papillomavirus DNA gene sequences in human breast cancer FREE

C-Y Kan, B J Iacopetta, J S Lawson and N J Whitaker

Br J Cancer 93: 946-948; doi:10.1038/sj.bjc.6602778

Interaction between the bone morphogenetic proteins and Ras/MAP-kinase signalling pathways in lung cancer FREE

K S Kraunz, H H Nelson, M Liu, J K Wiencke and K T Kelsey

Br J Cancer 93: 949-952; advance online publication, September 20, 2005; doi:10.1038/sj.bjc.6602790

Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma FREE

I U Ali, B T Luke, M Dean and P Greenwald

Br J Cancer 93: 953-959; advance online publication, October 4, 2005; doi:10.1038/sj.bjc.6602806

Top

Letter to the Editor

Monitoring of circulating tumour-associated DNA as a prognostic tool for oral squamous cell carcinoma FREE

E Thomas, R J Shaw and J M Risk

Br J Cancer 93: 960; advance online publication, October 4, 2005; doi:10.1038/sj.bjc.6602801

Top

Book Review

Imaging in Oncology FREE

J Hague and M A Hall-Craggs

Br J Cancer 93: 961; doi:10.1038/sj.bjc.6602766

The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.

Extra navigation

ADVERTISEMENT